Xu QG - Search Results

1

Aldolase B inhibits metastasis through Ten-Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma.

Tao QF, Yuan SX, Yang F, Yang S, Yang Y, Yuan JH, Wang ZG, Xu QG, Lin KY, Cai J, Yu J, Huang WL, Teng XL, Zhou CC, Wang F, Sun SH, Zhou WP. Tao QF, et al. Among authors: xu qg. Mol Cancer. 2015 Sep 17;14:170. doi: 10.1186/s12943-015-0437-7. Mol Cancer. 2015. PMID: 26376879 Free PMC article.

2

Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1.

Yuan SX, Wang J, Yang F, Tao QF, Zhang J, Wang LL, Yang Y, Liu H, Wang ZG, Xu QG, Fan J, Liu L, Sun SH, Zhou WP. Yuan SX, et al. Among authors: xu qg. Hepatology. 2016 Feb;63(2):499-511. doi: 10.1002/hep.27893. Epub 2015 Jul 22. Hepatology. 2016. PMID: 25964079

3

Long noncoding RNA, the methylation of genomic elements and their emerging crosstalk in hepatocellular carcinoma.

Yuan SX, Zhang J, Xu QG, Yang Y, Zhou WP. Yuan SX, et al. Among authors: xu qg. Cancer Lett. 2016 Sep 1;379(2):239-44. doi: 10.1016/j.canlet.2015.08.008. Epub 2015 Aug 14. Cancer Lett. 2016. PMID: 26282784 Review.

4

The Prediction of Clinical Outcome in Hepatocellular Carcinoma Based on a Six-Gene Metastasis Signature.

Yuan S, Wang J, Yang Y, Zhang J, Liu H, Xiao J, Xu Q, Huang X, Xiang B, Zhu S, Li L, Liu J, Liu L, Zhou W. Yuan S, et al. Clin Cancer Res. 2017 Jan 1;23(1):289-297. doi: 10.1158/1078-0432.CCR-16-0395. Epub 2016 Jul 22. Clin Cancer Res. 2017. PMID: 27449498

5

Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma.

Hu L, Wang RY, Cai J, Feng D, Yang GZ, Xu QG, Zhai YX, Zhang Y, Zhou WP, Cai QP. Hu L, et al. Among authors: xu qg. Oncotarget. 2016 Oct 11;7(41):66660-66678. doi: 10.18632/oncotarget.11433. Oncotarget. 2016. PMID: 27556502 Free PMC article.

6

Paraoxonase 3 inhibits cell proliferation and serves as a prognostic predictor in hepatocellular carcinoma.

Cai J, Yuan SX, Yang F, Tao QF, Yang Y, Xu QG, Wang ZG, Yu J, Lin KY, Wang ZY, Ma JZ, Zhou CC, Wang F, Sun SH, Zhou WP. Cai J, et al. Among authors: xu qg. Oncotarget. 2016 Oct 25;7(43):70045-70057. doi: 10.18632/oncotarget.12145. Oncotarget. 2016. PMID: 27661119 Free PMC article.

7

METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N⁶ -methyladenosine-dependent primary MicroRNA processing.

Ma JZ, Yang F, Zhou CC, Liu F, Yuan JH, Wang F, Wang TT, Xu QG, Zhou WP, Sun SH. Ma JZ, et al. Among authors: xu qg. Hepatology. 2017 Feb;65(2):529-543. doi: 10.1002/hep.28885. Epub 2016 Dec 24. Hepatology. 2017. PMID: 27774652

8

Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.

Yu J, Xu QG, Wang ZG, Yang Y, Zhang L, Ma JZ, Sun SH, Yang F, Zhou WP. Yu J, et al. Among authors: xu qg. J Hepatol. 2018 Jun;68(6):1214-1227. doi: 10.1016/j.jhep.2018.01.012. Epub 2018 Jan 31. J Hepatol. 2018. PMID: 29378234

9

IL-17A promotes the invasion-metastasis cascade via the AKT pathway in hepatocellular carcinoma.

Xu QG, Yu J, Guo XG, Hou GJ, Yuan SX, Yang Y, Yang Y, Liu H, Pan ZY, Yang F, Gu FM, Zhou WP. Xu QG, et al. Mol Oncol. 2018 Jun;12(6):936-952. doi: 10.1002/1878-0261.12306. Epub 2018 Apr 26. Mol Oncol. 2018. PMID: 29689643 Free PMC article.

10

Overactivated neddylation pathway in human hepatocellular carcinoma.

Yu J, Huang WL, Xu QG, Zhang L, Sun SH, Zhou WP, Yang F. Yu J, et al. Among authors: xu qg. Cancer Med. 2018 Jul;7(7):3363-3372. doi: 10.1002/cam4.1578. Epub 2018 May 30. Cancer Med. 2018. PMID: 29846044 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters